Nov 26, 2019Alpha Tau Announces the Publication of Exceptional Clinical Data from Alpha DaRT, its Novel Alpha RaAlpha DaRT™ achieves a 78.6% complete response rate in management of challenging squamous cell carcinoma tumors. Tel Aviv, Israel,...
Oct 14, 2018The Birth of Alpha Tau Medical – the Medicine Researcher PerspectiveCancer is the most devastating chronic disease affecting humankind. More than 1 out of 3 people in the United States will have cancer...